BioSpace News Archive

Drug Development

Arcutis, Inc Announces Positive Top Line Results for Phase 2b Clinical Trial Evaluating ARQ-151 as a Potential Topical Treatment for Plaque Psoriasis

Arcutis, Inc., a privately held immuno-dermatology drug development company addressing significant unmet needs in dermatology, announced positive top line results for its Phase 2b study evaluating ARQ-151 as a potential topical treatment for plaque psoriasis.

July 22, 2019
·
5 min read
Combined online self-management for pain, associated anxiety and depression works

Online self-management helps; for some the online system plus nurse telecare helps more

July 22, 2019
·
4 min read
Pharmaceutical Clean Room Qualification Verifies Secure Operation

In the pharmaceutical industry, continuous and secure data acquisition and documentation is crucial for production and storage requirements, and also for research and development.

July 22, 2019
·
3 min read
Drug Development

Achillion’s ACH-5228 Achieves Positive Results In Phase 1 Multiple Ascending Dose Study In Healthy Volunteers

Achillion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and families affected by complement-mediated diseases, announced results from their Phase 1 multiple ascending dose study with ACH-5228 outside of the United States.

July 22, 2019
·
7 min read
Business

InvestAcure Honors 10 Leading Scientists With the Cure Coin Award for Work Developing Alzheimer’s Diagnostics and Treatments

InvestAcure, PBC, honored 10 leading bioindustry scientists with the Cure Coin Award for their outstanding work developing groundbreaking scientific discoveries into lifesaving therapeutics for Alzheimer’s, CTE and other related Dementias.

July 22, 2019
·
4 min read